Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
The Role of DNA Methylation in Pediatric Cancer |
Fred Hutchinson Cancer Research Center / Scott Diede |
Young Investigator Grants |
2010 |
Washington |
Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition |
St. Jude Children’s Research Hospital / Adam Durbin, PhD |
Young Investigator Grants |
2018 |
Tennessee |
The Role of Prmt1 in Osteosarcoma Initiation and Metastasis |
Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Identification of Alveolar Rhabdomyosarcoma "Achilles' Heel" |
National Cancer Institute / Fernanda Arnaldez |
Young Investigator Grants |
2011 |
Maryland |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia |
Massachusetts General Hospital / Jessica Blackburn, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells |
Stanford University / Ramin Dubey, PhD |
Young Investigator Grants |
2015 |
California |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |